DP Quality Consulting is an independent pharmaceutical quality and regulatory consultancy. Our team has held senior quality and compliance roles inside drug manufacturing organizations, which shapes how we advise: every recommendation is weighed against what a plant can realistically execute and sustain.
We work across the categories where regulatory scrutiny is highest — sterile and non-sterile manufacturing, branded and generic products, contract and compounded operations — bringing the same rigor to a five-person compounding pharmacy as to a multinational manufacturer.
Every recommendation is grounded in current FDA cGMP requirements (21 CFR Parts 210 and 211) and ICH Q9/Q10 quality risk management principles.
Our engagement experience spans drug manufacturers and CMOs across the Americas, Europe, and Asia.